Compositions and methods are provided for inhibiting the expression of human tumor necrosis factor- alpha (TNF- alpha ). Antisense oligonucleotides targeted to nucleic acids encoding TNF- alpha are preferred. Methods of using these oligonucleotides for inhibition of TNF- alpha expression and for treatment of diseases, particularly inflammatory and autoimmune diseases, associated with overexpression of TNF- alpha are provided.
